All Articles

A new AI tool is replacing spreadsheets, helping firms make faster, data-backed decisions on when to replace vehicles, saving millions in the process.

With 61% of its students being the first in their families to attend college, Goodwin's new initiatives offer more than support—they offer a national blueprint.

As TuHURA Biosciences takes the stage at a key investor conference, its multi-pronged attack on immunotherapy resistance faces a critical test.

As Premium Brands preps its Q2 results, investors are watching if its U.S. acquisition strategy can offset seafood struggles and inflationary pressures.

With $8M in new funding, Tikva Allocell is advancing a novel cell therapy that uses armored, virus-specific T cells to overcome historical barriers in cancer.

The young brokerage's launch of options on futures, powered by Devexperts, isn't just a product update—it's a direct challenge to established players.

Rockwell Medical's hire of Brian Cox signals a strategic push to bolster quality and compliance, a critical move for expansion in the high-stakes hemodialysis market.

With UK approval for its FLAMINGO-01 trial, Greenwich LifeSciences partners with a top cancer center, signaling a key move in the race to prevent breast cancer recurrence.

In a decisive strategic pivot, MAS and SPARC divested its medical staffing unit to focus on the booming home and community-based care sectors. Why?

While others chase fleeting trends, EMERGE Commerce builds a durable portfolio. A deep dive into how its niche strategy is redefining success in e-commerce.

With a veteran team from Meta and Snowflake and a massive $180M war chest, Glow is betting it can win the AI security arms race with a radical new model.

Marquis MD's new concierge clinic promises a cure for healthcare's frustrations. But as it caters to the elite, does it widen the care gap for everyone else?

How CSTS and Connexus navigated a tri-nation World Cup to achieve record sales, signaling a new era for premium sports tourism in Greater China.

With the hire of AI pioneer Dan Hinckley, rapidly growing Herringbone signals a move beyond acquisition, betting its future on a unified AI-driven platform.

Science Corp.'s PRIMA device is a medical miracle, restoring sight to those with AMD. But can this BCI breakthrough navigate Europe's complex market hurdles?

Beyond CO2, a potent gas threatens our climate. A new Chinese technology offers a 'near-zero' emissions solution, providing a blueprint for the world.

Joby and Virgin Atlantic's new deal isn't just a headline; it's a blueprint for integrated, electric flight, promising to shrink UK cities in minutes.

GoldMining Inc. unveils a compelling economic case for its São Jorge gold project in Brazil, but the path from promising study to profitable mine is fraught with risk.

A new satellite partnership promises an ultra-secure, space-only network for Central Asia, challenging the LEO status quo and raising the stakes for global data security.